Jori E. May

755 total citations
43 papers, 429 citations indexed

About

Jori E. May is a scholar working on Internal Medicine, Surgery and Hematology. According to data from OpenAlex, Jori E. May has authored 43 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Internal Medicine, 11 papers in Surgery and 11 papers in Hematology. Recurrent topics in Jori E. May's work include Venous Thromboembolism Diagnosis and Management (14 papers), Heparin-Induced Thrombocytopenia and Thrombosis (9 papers) and Intramuscular injections and effects (5 papers). Jori E. May is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (14 papers), Heparin-Induced Thrombocytopenia and Thrombosis (9 papers) and Intramuscular injections and effects (5 papers). Jori E. May collaborates with scholars based in United States, United Kingdom and India. Jori E. May's co-authors include Marisa B. Marques, Radhika Gangaraju, Stephan Moll, Vishnu Reddy, Jennifer Jones, Olaf Kutsch, Frédéric Wagner, Frédéric Bibollet‐Ruche, Alexandra Duverger and Randy Q. Cron and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jori E. May

37 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jori E. May United States 10 102 78 78 69 66 43 429
George Goshua United States 8 34 0.3× 30 0.4× 101 1.3× 16 0.2× 59 0.9× 55 354
Vincent Raimondi France 7 48 0.5× 41 0.5× 90 1.2× 20 0.3× 45 0.7× 7 453
Όλγα Κατσαρού Greece 17 156 1.5× 21 0.3× 179 2.3× 25 0.4× 28 0.4× 45 782
Anastasia Polycarpou Greece 12 40 0.4× 46 0.6× 213 2.7× 29 0.4× 294 4.5× 15 724
Joan S. Chmiel United States 7 62 0.6× 175 2.2× 101 1.3× 17 0.2× 20 0.3× 7 484
Lucile Amrouche France 13 11 0.1× 62 0.8× 107 1.4× 58 0.8× 88 1.3× 32 674
Dilek Arikan United States 11 66 0.6× 34 0.4× 93 1.2× 21 0.3× 30 0.5× 25 417
E. B. Haagsma Netherlands 13 11 0.1× 104 1.3× 35 0.4× 43 0.6× 89 1.3× 28 668
D. Niese Germany 12 32 0.3× 48 0.6× 52 0.7× 83 1.2× 57 0.9× 43 573
Mabel Toribio United States 11 99 1.0× 10 0.1× 108 1.4× 19 0.3× 31 0.5× 32 419

Countries citing papers authored by Jori E. May

Since Specialization
Citations

This map shows the geographic impact of Jori E. May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jori E. May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jori E. May more than expected).

Fields of papers citing papers by Jori E. May

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jori E. May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jori E. May. The network helps show where Jori E. May may publish in the future.

Co-authorship network of co-authors of Jori E. May

This figure shows the co-authorship network connecting the top 25 collaborators of Jori E. May. A scholar is included among the top collaborators of Jori E. May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jori E. May. Jori E. May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuker, Adam, David García, Ming Y. Lim, et al.. (2025). Foundations of systems-based hematology: thematic analysis of expert interviews to guide curriculums and promote growth. Blood Advances. 10(6). 2038–2046.
2.
Patell, Rushad, Dana E. Angelini, Jordan K. Schaefer, et al.. (2025). Patient-centered management of heavy menstrual bleeding while on anticoagulation: A survey study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 313. 114650–114650.
3.
Westbrook, Brian C., et al.. (2024). Limitations of a platelet count-based clinical decision support system to facilitate diagnosis of heparin-induced thrombocytopenia. Thrombosis Research. 243. 109171–109171. 1 indexed citations
4.
May, Jori E., et al.. (2024). Electronic consultation to improve care outcomes in patients with suspected and confirmed heparin-induced thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 8(5). 102537–102537. 1 indexed citations
5.
May, Jori E., et al.. (2024). Safe and effective anticoagulation use: case studies in anticoagulation stewardship. Journal of Thrombosis and Haemostasis. 23(3). 779–789.
6.
May, Jori E., Brian C. Westbrook, & Adam Cuker. (2023). Heparin-induced thrombocytopenia: An illustrated review. Research and Practice in Thrombosis and Haemostasis. 7(5). 100283–100283. 17 indexed citations
7.
McFarland, Mary, et al.. (2023). Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review. Research and Practice in Thrombosis and Haemostasis. 7(7). 102219–102219. 6 indexed citations
8.
Tsitsikas, Dimitris A., et al.. (2022). Pitfalls in Diagnosing Thrombotic Thrombocytopenic Purpura in Sickle Cell Disease. Journal of Clinical Medicine. 11(22). 6676–6676. 1 indexed citations
9.
Durani, Urshila, Ajay Major, Ana I. Velázquez, et al.. (2022). Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment. JCO Oncology Practice. 18(4). e586–e599. 8 indexed citations
10.
Pepin, Mark E., et al.. (2021). A case of “smoldering” immune‐mediated thrombotic thrombocytopenic purpura manifesting as recurrent cardioembolic stroke. SHILAP Revista de lepidopterología. 9(10). e04850–e04850. 1 indexed citations
11.
May, Jori E., Alisa S. Wolberg, & Ming Y. Lim. (2021). Disorders of Fibrinogen and Fibrinolysis. Hematology/Oncology Clinics of North America. 35(6). 1197–1217. 26 indexed citations
12.
Davies, Elizabeth, et al.. (2021). Oncology Patient Smoking Cessation Treatment Preferences: Perceptions Across Former and Current Cigarette Smokers. Journal of Cancer Education. 37(6). 1975–1981. 1 indexed citations
13.
May, Jori E., et al.. (2020). Co-Occurrence of Familial Hemophagocytic Lymphohistiocytosis Type 2 and Chronic Active Epstein-Barr Virus in Adulthood. The American Journal of the Medical Sciences. 361(3). 388–393. 5 indexed citations
14.
May, Jori E., et al.. (2020). Current Practice and Clinical Utility of Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 29(11). 105209–105209. 4 indexed citations
15.
May, Jori E., Marisa B. Marques, Vishnu Reddy, & Radhika Gangaraju. (2019). Three neglected numbers in the CBC: The RDW, MPV, and NRBC count. Cleveland Clinic Journal of Medicine. 86(3). 167–172. 61 indexed citations
16.
May, Jori E., et al.. (2017). Pivot and Cluster: An Exercise in Clinical Reasoning. Journal of General Internal Medicine. 33(2). 226–230. 3 indexed citations
17.
Sonpavde, Guru, et al.. (2017). Prevalence of Measurable Disease in Metastatic Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. 15(5). 534–539. 3 indexed citations
18.
May, Jori E., Kenneth R. Carson, Sara K. Butler, et al.. (2013). High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis. Leukemia & lymphoma. 55(6). 1345–1349. 74 indexed citations
19.
Duverger, Alexandra, Jennifer Jones, Jori E. May, et al.. (2009). Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency. Journal of Virology. 83(7). 3078–3093. 92 indexed citations
20.
Jones, Jennifer, Marintha Heil, Jori E. May, et al.. (2007). High Throughput Drug Screening for Human Immunodeficiency Virus Type 1 Reactivating Compounds. Assay and Drug Development Technologies. 5(2). 181–190. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Goshua Breakdown of academic impact, for papers by Vincent Raimondi Breakdown of academic impact, for papers by Όλγα Κατσαρού Breakdown of academic impact, for papers by Anastasia Polycarpou Breakdown of academic impact, for papers by Joan S. Chmiel Breakdown of academic impact, for papers by Lucile Amrouche Breakdown of academic impact, for papers by Dilek Arikan Breakdown of academic impact, for papers by E. B. Haagsma Breakdown of academic impact, for papers by D. Niese Breakdown of academic impact, for papers by Mabel Toribio
Rankless by CCL
2026